Long term prognosis of children born to lupus patients

A Murashima1, T Fukazawa, M Hirashima

  • 1Department of Maternal Medicine, National Centre for Child Health and Development, Tokyo, Japan. murasima-a@ncchs.go.jp

Insights

Children born to mothers with systemic lupus erythematosus (SLE) show a high prevalence of antinuclear antibodies (ANA), suggesting a genetic link. Further studies are needed to understand SLE pathogenesis.

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with complex etiology.
  • Understanding the long-term prognosis and potential genetic predispositions in offspring of SLE patients is crucial.

Purpose of the Study:

  • To investigate the long-term health outcomes and immunological markers in children of patients diagnosed with SLE.
  • To identify potential genetic factors contributing to SLE pathogenesis in the offspring.

Main Methods:

  • A cohort of 195 children (4 months to 26 years) with SLE-affected parents underwent physical examinations and laboratory testing.
  • Blood samples were analyzed for antinuclear antibodies (ANA), anti-DNA antibodies, and antiphospholipid antibodies.
  • Data collection occurred across multiple visits between 1991 and 1998.

Main Results:

  • 27% of children tested positive for ANA, significantly higher than the 7% in control groups.
  • ANA positivity was more frequent in female children, particularly girls aged 4-8 years.
  • Anti-DNA and antiphospholipid antibody incidence did not differ significantly from controls.

Conclusions:

  • A high rate of ANA positivity in children of SLE patients suggests a significant genetic component in SLE development.
  • Longitudinal monitoring of these children is essential for gaining insights into SLE pathogenesis and clinical progression.
Abstract